Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

Head Neck. 2010 Sep;32(9):1195-201. doi: 10.1002/hed.21315.

Abstract

Background: In accord with the cancer stem cell (CSC) theory, only a small subset of cancer cells are capable of forming tumors. We previously reported that CD44 isolates tumorigenic cells from head and neck squamous cell cancer (HNSCC). Recent studies indicate that aldehyde dehydrogenase (ALDH) activity may represent a more specific marker of CSCs.

Methods: Six primary HNSCCs were collected. Cells with high and low ALDH activity (ALDH(high)/ALDH(low)) were isolated. ALDH(high) and ALDH(low) populations were implanted into NOD/SCID mice and monitored for tumor development.

Results: ALDH(high) cells represented a small percentage of the tumor cells (1% to 7.8%). ALDH(high) cells formed tumors from as few as 500 cells in 24/45 implantations, whereas only 3/37 implantations of ALDH(low) cells formed tumors.

Conclusions: ALDH(high) cells comprise a subpopulation cells in HNSCCs that are tumorigenic and capable of producing tumors at very low numbers. This finding indicates that ALDH activity on its own is a highly selective marker for CSCs in HNSCC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aldehyde Dehydrogenase / analysis
  • Aldehyde Dehydrogenase / metabolism*
  • Animals
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Squamous Cell / pathology*
  • Cell Line, Tumor
  • Cell Separation
  • Cell Survival
  • Female
  • Flow Cytometry
  • Head and Neck Neoplasms / pathology*
  • Humans
  • Male
  • Mice
  • Mice, Inbred NOD
  • Middle Aged
  • Models, Animal
  • Neoplastic Stem Cells / pathology*
  • Sensitivity and Specificity

Substances

  • Biomarkers, Tumor
  • Aldehyde Dehydrogenase